Acne Drugs Market by Type (Comedonal, Inflammatory, Cystic, and Postsurgical/wound), Therapeutic Class (Retinoid, Antibiotic, Hormonal Agent, Combination, and Others), and Mode of Administration (Topical, Oral, and Injectable), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031
Acne Drugs Market outlook 2031:
The global acne drugs market size was valued at USD 10.38 Billion in 2022 and is projected to reach USD 16.40 Billion by 2031, expanding at a CAGR of 5.1% during the forecast period 2023 - 2031. The growth of the market is attributed to the introduction of biologics, unhealthy lifestyle, and increasing disease prevalence.
Acne is a chronic, inflammatory skin disorder that produces pimples and spots on the face, shoulders, back, neck, chest, and upper arms, among other areas. Acne develops when oil, dead skin, or germs clog the pores of the skin. Each skin pore is a follicle's opening. A hair and a sebaceous (oil) gland make up the follicle. Sebum (oil) is produced by the oil gland and travels up the hair shaft, out of the pore, and onto the skin. Sebum lubricates and softens the skin.
Acne can be caused by one or more issues with the lubrication process. It can happen when your follicles generate too much oil, dead skin cells pile up in your pores, or bacteria build up in your pores. All of these issues lead to the formation of pimples. When bacteria develop in a blocked pore and the oil cannot leave, a pimple form.
Acne has a lot of misconceptions regarding what causes it. Many individuals believe that certain foods, such as chocolate and French fries, cause acne. While there is no scientific evidence to back up these assertions, there are certain risk factors for acne. Hormonal changes brought on by puberty or pregnancy, certain drugs such as birth control pills or corticosteroids, a diet heavy in refined sugars or carbs such as bread and chips and having acne-prone parents are all risk factors.
Acne is more common in young people throughout puberty. The body goes through hormonal changes at this period. These changes may increase oil production, putting you at risk for acne. When you reach maturity, hormonal acne associated with puberty typically fades or improves. It is crucial to figure out the type of acne individual have before starting its treatment. Acne can be either non-inflammatory or inflammatory in nature. Blackheads, whiteheads, papules, pustules, nodules, and cysts are all forms of acne that fall into these two categories.
If self-care is not working, there are a few over-the-counter acne medicines to try. The majority of these medicines contain chemicals that can aid in the killing of germs or the reduction of oil on the skin. Benzoyl peroxide, which is found in many acne treatments and gels, is one of them. It is used to dry up existing pimples and prevent new ones from forming. Acne-causing bacteria are also killed by benzoyl peroxide. Sulfur is a natural component that may be found in certain lotions, cleansers, and masks and has a unique odor.
Resorcinol is a less commonly used chemical for exfoliating dead skin cells. Soaps and acne wash frequently include salicylic acid. It aids in the prevention of clogged pores. Pimples are a common skin condition that can be frustrating to cure. Applying essential oils, green tea, and aloe vera to the skin appears to be the quickest solution to get rid of pimples, whereas supplements, according to some limited study, may require longer-term use.
Acne Drugs Market Trends, Drivers, Restraints, and Opportunities
- Increasing prevalence of skin-related diseases, such as acne vulgaris is key factors driving the market growth during the forecast period.
- Rising awareness among the consumers regarding the benefits of skin care products is expected to boost the market growth in the coming years.
- Increasing consumer demand for products made with natural ingredients is expected to fuel the market growth during the forecast period.
- Increasing clinical drug approvals for acne treatment is anticipated to propel the market growth during the forecast period.
- Adoption of unhealthy lifestyle by teenagers and availability of wide variety of products such as lotions, creams and gels constituting antibiotic agents are major factors fueling the market growth during the forecast period.
- Side effects associated with several acne products are projected to hamper the market growth during the forecast period.
- Increased R&D investments for development of novel products and therapies with improved efficacy and technological advancements are estimated to offer lucrative opportunities for the market players.
Scope of Acne Drugs Market Report
The report on the global acne drugs market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Acne Drugs Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Type (Comedonal, Inflammatory, Cystic, and Postsurgical/wound), Therapeutic Class (Retinoid, Antibiotic, Hormonal Agent, Combination, and Others), and Mode of Administration (Topical, Oral, and Injectable) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Alma Lasers Ltd.; Lumenis Ltd.; Cutera, Inc.; Stiefel Laboratories Inc.; GlaxoSmithKline Plc.; Galderma S.A.; Valeant Pharmaceutical International, Inc.; Verilux, Inc.; Johnson and Johnson; Syneron Medical Ltd; and Allergan plc. |
Acne Drugs Market Segment Insights
Inflammatory segment is expected to account for a key share
Based on type, the acne drugs market is segmented into comedonal, inflammatory, cystic, and postsurgical/wound. The inflammatory segment is expected to account for a key share of the market during the forecast period owing to its increasing demand worldwide. Symptoms of inflammatory acne include redness, swelling, and severely clogged pores filled with dirt, germs, and dead skin cells. Bacterial infection might exacerbate the problem.
Cystic acne is the most severe type of acne and affects a smaller number of people. The majority of over-the-counter medications are ineffective in treating cystic acne. After a bacterial infection at the wound/surgery site, post-surgical/wound acne develops.
Retinoids and antibiotics segment are expected to constitute a key share
Based on therapeutic class, the acne drugs market is segmented into retinoid, antibiotic, hormonal agent, combination, and others. The retinoids and antibiotics segment are expected to constitute a key share of the market during the forecast period owing to their first-line action and impending approval of pipeline products.
On the other hand, the combination segment is anticipated to expand at a rapid pace during the forecast period owing to its higher efficacy, improved results, reduced resistance, and convenient usage. Hormonal agents are usually utilized in the most serious situations. Oral contraception is a common type of hormonal acne therapy.
Women who, in addition to suffering from acne, are interested in contraceptive advantages typically prefer this technique. Hormonal treatment, on the other hand, is used in conjunction with benzoyl peroxide, azelaic acid, antibiotics, and retinoids. Sulfur, hydroxy acids, BPO, salicylic acid, and azelaic acid are some of the other treatments employed.
Topical segment is expected to represent a key share
Based on mode of administration, the acne drugs market is segmented into topical, oral, and injectable. The topical segment is expected to represent a key share of the market during the forecast period as for mild-to-moderate acne and maintenance therapy, retinoids, antibiotics, BPO, salicylic acid, and azelaic acid are used topically. When topical treatments fail to elicit a response, oral medicines are indicated as systemic therapy.
On the other hand, the injectable segment is anticipated to expand at a rapid pace during the forecast period owing to introduction of several biologics. Cortisone injections may be required to treat highly inflammatory or cystic acne.
North America is anticipated to dominate the market
On the basis of regions, the acne drugs market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to lifestyle changes, rising disease incidence, and easy availability of products.
On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increased number of product launches, high demand for effective acne treatment, growing healthcare expenditure, and rising awareness regarding the treatment options.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Acne Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Acne Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Acne Drugs Market - Supply Chain
4.5. Global Acne Drugs Market Forecast
4.5.1. Acne Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Acne Drugs Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Acne Drugs Market Absolute $ Opportunity
5. Global Acne Drugs Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Acne Drugs Market Size and Volume Forecast by Types
5.3.1. Comedonal
5.3.2. Inflammatory
5.3.3. Cystic
5.3.4. Postsurgical/wound
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Acne Drugs Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Acne Drugs Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Acne Drugs Demand Share Forecast, 2019-2026
7. North America Acne Drugs Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Acne Drugs Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Acne Drugs Market Size and Volume Forecast by Types
7.4.1. Comedonal
7.4.2. Inflammatory
7.4.3. Cystic
7.4.4. Postsurgical/wound
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Acne Drugs Demand Share Forecast, 2019-2026
8. Latin America Acne Drugs Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Acne Drugs Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Acne Drugs Market Size and Volume Forecast by Types
8.4.1. Comedonal
8.4.2. Inflammatory
8.4.3. Cystic
8.4.4. Postsurgical/wound
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Acne Drugs Demand Share Forecast, 2019-2026
9. Europe Acne Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Acne Drugs Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Acne Drugs Market Size and Volume Forecast by Types
9.4.1. Comedonal
9.4.2. Inflammatory
9.4.3. Cystic
9.4.4. Postsurgical/wound
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Acne Drugs Demand Share Forecast, 2019-2026
10. Asia Pacific Acne Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Acne Drugs Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Acne Drugs Market Size and Volume Forecast by Types
10.4.1. Comedonal
10.4.2. Inflammatory
10.4.3. Cystic
10.4.4. Postsurgical/wound
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Acne Drugs Demand Share Forecast, 2019-2026
11. Middle East & Africa Acne Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Acne Drugs Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Acne Drugs Market Size and Volume Forecast by Types
11.4.1. Comedonal
11.4.2. Inflammatory
11.4.3. Cystic
11.4.4. Postsurgical/wound
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Acne Drugs Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Acne Drugs Market: Market Share Analysis
12.2. Acne Drugs Distributors and Customers
12.3. Acne Drugs Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Alma Lasers Ltd.
12.4.2. Lumenis Ltd.
12.4.3. Cutera, Inc.
12.4.4. Stiefel Laboratories Inc.
12.4.5. GlaxoSmithKline Plc.
12.4.6. Galderma S.A.
12.4.7. Valeant Pharmaceutical International, Inc.
12.4.8. Verilux, Inc.